NEW YORK (GenomeWeb) – Separate lawsuits that Illumina has filed against several companies in the UK for allegedly infringing on three of its patents related to its noninvasive prenatal test will be heard in conjunction with each other in 2017.
Registering provides access to this and other free content.
Already have an account?Login Now.
The New York Times reports that as China invests in science, it also is dealing with research fraud.
In PLOS this week: transcriptome study of a cold-tolerant plant, deep sequencing of clinical influenza A samples, and more.
The Atlantic writes that retrotransposons like BovB have proliferated in a number of genomes.
Researchers have sequenced the genome of a man who lived in China some 40,000 years ago, according to UPI.
This webinar will discuss the advantages of a multiple-biomarker-based approach for immune profiling that provides clinicians with a rational means to consider approved immunotherapies or assign patients to immunotherapy clinical trials.
This webinar will discuss the benefits of using unique molecular indices to overcome some challenges associated with next-generation sequencing panels.
This webinar will discuss the role of a newly discovered, brain-enriched form of non-CpG DNA methylation in neural development and disease.
This webinar will discuss a molecular barcode-based error correction method that enables combined mutation detection and DNA copy number profiling through circulating tumor DNA sequencing.